Treatment of Non-small Cell Lung Cancer-Stage IIIA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Non-small Cell Lung Cancer-Stage IIIA

Published:2007-09 Issue:3 Volume:132 Page:243S-265S
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Robinson Lary A.,Ruckdeschel John C.,Wagner Henry,Stevens Craig W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference113 articles.

1. Revisions in the International System for staging lung cancer;Mountain;Chest,1997

2. Combined modality therapy of non-small cell lung cancer;Ruckdeschel;Semin Oncol,1997

3. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging;Fernando;Cancer,1990

4. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastases (N2 disease);Goldstraw;J Thorac Cardiovasc Surg,1994

5. Should subcarinal nodes be routinely examined in patients with non-small cell lung cancer? The Lung Cancer Study Group;J Thorac Cardiovasc Surg,1988

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologische Diagnostik und Biomarker für die perioperative Systemtherapie;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-08

2. GWO+RuleFit: rule-based explainable machine-learning combined with heuristics to predict mid-treatment FDG PET response to chemoradiation for locally advanced non-small cell lung cancer;Physics in Medicine & Biology;2024-07-23

3. Recurrence/prognosis estimation using a molecularly positive surgical margin‐based model calls for alternative curative strategies in pIIIA/N2 NSCLC;Molecular Oncology;2024-02-07

4. Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study);Frontiers in Immunology;2024-01-15

5. Phase I/II study to evaluate consolidative hypofractionated radiation therapy for boosting the residual primary disease in combination with durvalumab after definitive chemoradiation therapy for stage III non-small cell lung cancer (NSCLC): study protocol for a prospective trial;Journal of Thoracic Disease;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3